Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lurasidone adjunctive to lithium or divalproex in bipolar I disorder
NCT01358357Phase 3Completed
- Sponsor
- Sumitomo Pharma America
- Start
- Jun 2011
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of lurasidone in bipolar I disorder, sponsored by Sumitomo Pharma America. Started Jun 2011; status: completed.
02
Drugs
lurasidone
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT01358357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01358357.